In conclusion, our study reveals that the chemerin/CMKLR1 axis promotes PASMC proliferation and migration by activating the ERK1/2 signaling pathway, and chemerin protein levels are increased in the plasma of IPAH patients. This evidence concerns the gene CMKLR1 and idiopathic pulmonary arterial hypertension.